ArticleBMC infectious diseases2026
Machine learning prediction of in-hospital mortality risk among hospitalized patients with secondary bloodstream infection: a retrospective cohort study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSecondary bloodstream infection (SBSI) carries substantial mortality burden. Dedicated mortality prediction models with interpretable predictions remain limited.
objectiveTo develop an interpretable machine learning model for predicting in-hospital mortality in SBSI patients and establish a clinically applicable web-based tool.
methodsData from 340 SBSI patients (January 2020–December 2024) were analyzed. Candidate variables were selected using the union of multivariate Cox regression and LASSO-Cox regression. Five prognostic models were constructed including Cox regression, LASSO-Cox regression, Random Survival Forest (RSF), Gradient Boosting Machine (GBM), and XGBoost, with 10 selected variables as predictors. Model performance was evaluated using time-dependent Area Under the Receiver Operating Characteristic Curve (AUC) at 7, 14, and 28 days as the primary metric. Internal validation was conducted using bootstrap resampling with 1,000 iterations. The optimal RSF model was interpreted using SHapley Additive exPlanations (SHAP) analysis. An interactive web-based prediction tool was subsequently developed.
resultsIn-hospital all-cause mortality rate was 34.41% (117/340). Among the five models, RSF demonstrated superior discriminative ability with AUC values of 0.869 (95% CI: 0.824–0.914), 0.897 (95% CI: 0.856–0.937), and 0.878 (95% CI: 0.822–0.933) at 7, 14, and 28 days, respectively, substantially outperforming traditional Cox regression and LASSO-Cox models. RSF exhibited excellent calibration with corrected C-index of 0.8809. Decision curve analysis confirmed RSF’s clinical superiority, demonstrating the greatest net benefit across a wide range of threshold probabilities. SHAP analysis identified log Lactate Dehydrogenase, Multidrug-Resistant Organism infection, and log creatinine as the top three predictive features. An interactive web-based prediction tool was successfully developed enabling real-time risk assessment at 7, 14, and 28 days.
conclusionA interpretable machine learning model (RSF) for SBSI mortality prediction was successfully established. SHAP-based transparency and the interactive web-based tool facilitate clinical implementation and support personalized risk stratification for improved patient outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.